Sangani Hospitals Limited (NSE:SANGANI)
53.90
-0.60 (-1.10%)
Sep 11, 2026, 2:31 PM IST
Sangani Hospitals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 743 | 536 | 984 | 586 | - | - | |
Market Cap Growth | -26.42% | -45.52% | 68.00% | - | - | - |
Enterprise Value | 693 | 471 | 787 | 409 | - | - |
Last Close Price | 53.90 | 38.90 | 71.40 | 42.50 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 24.84 | 17.93 | 37.94 | 21.71 | - | - |
PS Ratio | 0.69 | 0.50 | 4.64 | 3.74 | - | - |
PB Ratio | 1.47 | 1.06 | 2.72 | 1.75 | - | - |
P/TBV Ratio | 1.81 | 1.31 | 2.73 | 1.75 | - | - |
P/FCF Ratio | - | - | 78.44 | 25.67 | - | - |
P/OCF Ratio | 14.92 | 10.77 | 41.93 | 17.38 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.64 | 0.44 | 3.72 | 2.61 | - | - |
EV/EBITDA Ratio | 7.98 | 5.42 | 31.42 | 13.00 | - | - |
EV/EBIT Ratio | 9.00 | 6.12 | 41.22 | 14.29 | - | - |
EV/FCF Ratio | - | - | 62.76 | 17.94 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.01 | 0.08 |
Debt / EBITDA Ratio | 0.15 | 0.15 | 0.03 | 0.03 | 0.03 | 0.13 |
Debt / FCF Ratio | - | - | 0.07 | 0.04 | - | 0.82 |
Net Debt / Equity Ratio | -0.29 | -0.29 | -0.50 | -0.57 | -0.24 | -0.55 |
Net Debt / EBITDA Ratio | -1.68 | -1.68 | -7.22 | -6.06 | -1.45 | -0.89 |
Net Debt / FCF Ratio | 420.93 | 420.93 | -14.42 | -8.37 | 0.46 | -5.61 |
Asset Turnover | 1.41 | 1.41 | 0.57 | 0.57 | 1.18 | 2.05 |
Inventory Turnover | 65.12 | 65.12 | 14.88 | 15.31 | 22.57 | 21.85 |
Quick Ratio | 1.27 | 1.27 | 9.01 | 14.56 | 4.84 | 3.39 |
Current Ratio | 1.34 | 1.34 | 9.62 | 15.09 | 5.40 | 3.79 |
Return on Equity (ROE) | 8.10% | 8.10% | 7.45% | 10.46% | 13.30% | 65.45% |
Return on Assets (ROA) | 6.30% | 6.30% | 3.20% | 6.50% | 9.48% | 37.16% |
Return on Invested Capital (ROIC) | 13.28% | 17.69% | 8.81% | 15.14% | 19.02% | 159.10% |
Return on Capital Employed (ROCE) | 14.60% | 14.60% | 5.20% | 8.40% | 11.10% | 54.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.03% | 5.58% | 2.64% | 4.61% | - | - |
FCF Yield | -0.05% | -0.07% | 1.27% | 3.90% | - | - |
Buyback Yield / Dilution | 0.10% | 0.00% | -11.02% | -31.24% | -139.50% | -133.86% |